PhD student researcher
Complutense University of Madrid, Spain
Pharmacy degree - University of 'La Sapienza' Rome in 2020. (vote:106/110)
Abilitated Pharmacist from University of 'La Sapienza' Rome. (2020)
Granted by Erasmus+ Traineeship in Complutense University of Madrid. Research
project tiitled: "Development of cannabinoid loaded nanoformulations " (2021).
Research Grant from University of 'La Sapienza' (2021-2022).
Selected as Best Abstract Award 2022 from AAPS award Committee, abstract titled:
"Development of Biodegradable Injectable In Situ Forming Implants for Controlled Release of
Cannabinoids: In Ovo Assessment." (2022).
Publications titled: '
-"Antibody‐Antineoplastic Conjugates in Gynecological Malignancies: Current Status and
Future Perspectives." Review Pharmaceutics 2021, 13, 1705.
-"Actively Targeted Nanomedicines in Breast Cancer: From Pre-Clinal Investigation to
Clinic." Cancers 2022, 14(5), 1198.
Book chapter: Nanomedicine application in cancer treatment« Author(s): Torres-Suárez,
A.*, Martín-Sabroso, C., Lozza, I., Fraguas-Sánchez, A. Book: "Handbook of Cancer and
Immunology". Editorial: Springer Status: Accepted (August 02, 2022).
Partecipation to the conferences:
-XXXIVème Congrès International de la Société de Pharmacie de la Méditerranée Latine.
(01/10/2021).
-XV Congreso de la Sociedad Española de Farmacia Industrial y Galénica Sevilla (España).
(02-04/12/2021).
-8th Galenus International workshop Valencia (ES). (27-29/04/2022)
-XV Jornada sobre la tecnologia Farmaceutica, Biofarmacia y Farmacocinetica. Facultad de
Farmacia Universidad Complutense de Madrid. Madrid (ES) (22/04/2022)
PhD student in the Department of Pharmaceutic and Food Technology, faculty of
Pharmacy. University Complutense of Madrid. (2021-ongoing).
Research Thesis focused on the development of innovative formulations for the
treatment of breast cancer, in particular TNBC using Cannabinoids.